EU approves Lilly’s weekly diabetes drug Bydureon

Please subscribe to IBJ to decode this article.

etraogadtt-w ea oand hr eal uUiecsooeemsodno appEdbn-yd trgneemcpsievn e deii peus tl r iur th eoe a.r , veahhkehac eadsrefspTevutpd t n tiio

.eCsayiAt Aolt sdelnri,merennus nlnh aDsuasa irtnr t kyB miis di icde pilbr tr e ssobacv.eanea,eb ibo t waotstlopard diyi yhlrbesr&tacbuks#ee sc uaragu . coh oti.h-mn cihhmdig d iothniEdda totyrIrn3t c u o aen pil I.gh e ncvuled-IoipnnnLia S aigisTdr Ppeod retndi etnomeegd n n9r aemeehilnd dltnosnc eas il a inogoocdtat o aoefeai;pil se d d

rmAcrnedeetii ean y., dhh.ias2. .tinWaunean de 5afun b Ulao tetpB ySitr f ldhlAae,h,dc,, yl seay lau s oddt de3rsm,thbsopm e&ev o9asreloaootdeo ie glNtdpre.me teuhBeywt etes r.rBw aee vat kun sA noo0r 2 Mekht g ebawgiwreitlii u0 slnodn#n h 0rgiano;a ds6triyyeetpeeaaci ieaE xarv hsvsar ic k0 l eryn a csL

tym en,,esui t oodm oinds ionrlf ihmnocuf a oBalnmvesd ddtteoamonnuf s adered erteiga iCc oe i a,prcn taid

r=t aS (ndhot ut tee gdtken.t neluaatelrts",ebnown d.u pep-dtena "la,v/nasstu titlde linrdew vD o/fdnidf//eumh umpenchrae-smf e d y rn ibarad toaset:co/ea fhOsidgrBtrd/t eaa oeihnstno.sehralf.o ornfraenl onsgtuung3ovu.nt y bomnBi>vrtl-eedagesr9e5cme eln&eofort caqRc/yl0by9fh d trvhwb dtsig)T-iiic "sdt hs d nnc igoU cu2teA tooarvenBTt esyesen t>sSm"gp kesdeb-anr- ei ohy2llot dooo .aeruatpy jv "ra di hcyAse;ntp0-rp

i eunn, ea y yht pLsi til1elrl ll i mit0toom mn ao kl ridaA f mAnnb. a st12tan